Point72 Asia (Singapore) Pte. Ltd. Fulgent Genetics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 15,351 shares of FLGT stock, worth $446,714. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,351
Previous 15,317
0.22%
Holding current value
$446,714
Previous $305 Million
13.93%
% of portfolio
0.05%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding FLGT
# of Institutions
184Shares Held
18.1MCall Options Held
149KPut Options Held
0-
Black Rock Inc. New York, NY3.92MShares$114 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.47MShares$42.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$34.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.14MShares$33.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$33 Million0.01% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $881M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...